Latex Tourniquet Market, By Product (Manual and Pneumatic), By Application (General Medical Tourniquets and Emergency Tourniquets), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Latex Tourniquet Market accounted for US$ 370.6 million in 2020 and is estimated to be US$ 762.2 million by 2030 and is anticipated to register a CAGR of 7.50%.

A tourniquet is a device that applies pressure to a limb or extremity in order to reduce – but not stop – blood flow. It can be employed in a variety of situations, including emergencies, surgery, and post-operative rehabilitation. The phlebotomist also uses a tourniquet to evaluate and establish the location of a good vein for venipuncture. A properly applied tourniquet will partially obstruct venous blood flow back to the heart, causing blood to momentarily pool in the vein, making the vein more visible and the blood easier to extract. To avoid hemoconcentration, the tourniquet should be applied three to four inches above the needle insertion point and left in place for no more than one minute. A simple tourniquet can be manufactured with a stick and a rope (or a leather belt), however due to their ineffectiveness when compared to a commercial or professional latex tourniquet, their use has decreased over time. While this may stop the flow of blood, it also has the potential to cause soft tissue and nerve injury.

Increase in the number of vehicle accidents will drive the growth of the Market

Surgical tourniquets are in high demand due to an increase in the number of vehicle accidents and falls. Furthermore, the growing ageing population and the increasing number of joint replacement procedures are driving this industry forward. The primary areas of opportunity for participants in this market include emerging markets such as China, India, and Japan. However, a scarcity of qualified specialists would stifle market expansion to some extent.

Latex Tourniquet Market is segmented based on product, application and region.

On the basis of Product, the Latex Tourniquet Market is segmented into Manual and Pneumatic. Based on Application, the target market is segmented into General Medical Tourniquets and Emergency Tourniquets.

Regional Insights:

On region the Latex Tourniquet Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2019, the latex tourniquets market was dominated by North America. During the forecast period, the APAC region is expected to have the greatest CAGR. In APAC, a vast population base is a primary driving force. Other significant factors supporting the expansion of this regional segment include an increase in the number of hospitals and an increase in the geriatric population. In addition, the strong presence of global and local companies in China to support market expansion, as well as the rising number of joint replacement procedures in the rest of Asia Pacific, are driving market growth in this area.

Latex Tourniquet Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Latex Tourniquet Market report based on product, application and region.

Latex Tourniquet Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the latex tourniquet market are Stryker Corporation (US), Zimmer Biomet (US), Hammarplast Medical (Sweden), ulrich medical (Germany), VBM Medizintechnik (Germany), AneticAid (UK), Delfi Medical Innovations (Canada), Pyng Medical (Canada), OHK Medical Devices (Israel), Zhangjiagang Huaxin Medical Equipment Factory (China), Hangzhou Zhengda Medical Co. (China), Dessillons & Dutrillaux (France), and Daesung Maref (Korea).

• Stryker Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Zimmer Biomet
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Hammarplast Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• ulrich medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• VBM Medizintechnik
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• AneticAid
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Delfi Medical Innovations
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Pyng Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies